Lene Kongsgaard Nielsen, Fredrik Schjesvold, Sören Möller, Nina Guldbrandsen, Markus Hansson, Kari Remes, . . . Madeleine T. King. (2024). Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: A randomized phase 2 trial by the Nordic Myeloma Study Group. SpringerOpen.
Chicago Style (17th ed.) CitationLene Kongsgaard Nielsen, et al. Health-related Quality of Life and Quality-adjusted Progression Free Survival for Carfilzomib and Dexamethasone Maintenance Following Salvage Autologous Stem-cell Transplantation in Patients with Multiple Myeloma: A Randomized Phase 2 Trial by the Nordic Myeloma Study Group. SpringerOpen, 2024.
MLA (9th ed.) CitationLene Kongsgaard Nielsen, et al. Health-related Quality of Life and Quality-adjusted Progression Free Survival for Carfilzomib and Dexamethasone Maintenance Following Salvage Autologous Stem-cell Transplantation in Patients with Multiple Myeloma: A Randomized Phase 2 Trial by the Nordic Myeloma Study Group. SpringerOpen, 2024.